Tobacco Regulation and Products Press Releases
WASHINGTON, DC - On Tuesday, May 24, the DC Council passed the FY23 Budget with funding for the Flavored Tobacco Product Prohibition Amendment Act of 2021 ending the sale of flavored tobacco products in the Distri
In yet another delay that leaves America’s kids at risk, the FDA has told a federal court that it won’t finish its review of marketing applications for the most popular e-cigarette products until June 2023 – nearly two years after the September 9, 2021, court-ordered deadline to do so.
The U.S. Food and Drug Administration (FDA) released its proposed rules today to eliminate menthol cigarettes and eliminate all flavors in all cigars.
Tobacco use rates among US adults hit an all-time low, but rates remain high among certain populations according to data released by the Centers for Disease Control and Prevention today.
American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients.
A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds youth tobacco use remains a serious public health threat.
Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.
Wednesday marks six months since the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other new tobacco product manufacturers’ applications.
head of the president’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is offering numerous policy suggestions for ways in which the administration and Congress can achieve the president’s ambitious Cancer Moonshot goal.
Statement from ACS CAN on the confirmation of FDA Commissioner Dr. Robert Califf